Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

EC Approves Additional Indication for Eisai's Anticancer Agent

May 10, 2016 2:00 pm | News | Comments

Halaven is a halichondrin class microtubule dynamics inhibitor with a distinct binding profile.

New Approach to Genetic Analysis Yields Markers to Complex Diseases

May 10, 2016 1:00 pm | by Anne Trafton, MIT News Office | News | Comments

Many diseases, such as cancer, diabetes, and schizophrenia, tend to be passed down through families.


Takeda Receives Gates Foundation Grant for Polio Vaccine

May 10, 2016 10:30 am | by Ryan Bushey, Digital Editor | Articles | Comments

The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.


Allergan Plans to Buy Back $10B in Shares, Posts 1Q Profit

May 10, 2016 10:23 am | by The Associated Press | News | Comments

Allergan shares rose 2 percent in premarket trading.


Better Way to Diagnose, Manage Neuroendocrine Tumors

May 10, 2016 8:56 am | by Society of Nuclear Medicine | News | Comments

These findings could have an impact on the future of nuclear medicine.


Treating Hep C: Pay Now or Pay More Later

May 10, 2016 8:55 am | by University of Southern California | News | Comments

The economic studies were funded by the Illinois-based pharmaceutical company AbbVie.


Valeant Pharma Promises to do Better with Deadlines

May 10, 2016 8:53 am | by The Associated Press | News | Comments

Shares of Valeant Pharmaceuticals are sharply higher after the embattled drug company promised to do better with financial filing deadlines.


First U.S. Lab Network to Offer Epigenomics’ Epi proColon

May 10, 2016 8:53 am | News | Comments

Epigenomics AG, the German-American cancer molecular diagnostics company, announced that Laboratory Corporation of America Holdings (LabCorp) is the first laboratory network in the U.S. to offer Epi proColon, a blood-based test for colorectal cancer screening.


Migraine Drugs Underused

May 10, 2016 8:40 am | by Thomas Jefferson University | News | Comments

Migraines are thought to cause pain because they cause a swelling of the blood vessels feeding the brain.


Global Study Identifies Safer Acute Stroke Treatment

May 10, 2016 8:33 am | by University of Leicester | News | Comments

The safety of a controversial clot-busting drug has been investigated by researchers.


Study Suggests New Treatment for Seizures

May 10, 2016 8:30 am | by eLife | News | Comments

Researchers have discovered a new factor in the escalation of seizures.


Immunotherapy Drug Shows Long-Lasting Response in Advanced Melanoma

May 9, 2016 3:41 pm | by UCLA | News | Comments

Pembrolizumab produces positive responses that are long-lasting and with fewer side effects than traditional treatments in people with advanced melanoma.


Gut-Brain Connection Moves into MS Territory

May 9, 2016 1:59 pm | by Harvard Gazette | News | Comments

Evidence suggests that bacteria living in the gut may remotely influence the activity of cells in the brain.


RNAi-Based Therapeutics: A Novel Platform for Drug Development

May 9, 2016 10:18 am | by Geert Cauwenbergh, Dr. Med. Sc, President and CEO of RXi Pharmaceuticals Corporation | Articles | Comments

The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics. 


Providing Safe, Targeted Drug Delivery to Placenta During Pregnancy

May 9, 2016 9:44 am | by University of California - Santa Barbara | News | Comments

More than 10 percent of pregnant women develop serious complications during pregnancy. The underlying cause is often a poorly functioning placenta, the organ that nourishes and maintains the fetus.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.